Yue Wang 王越 is an accomplished professional in the field of immunology, currently serving as Vice President of Immunology at Hansoh Bio since March 2024. Previously, Yue Wang held the position of Director of Oncology Immunotherapy at AstraZeneca from 2011 to the present and served as Vice President of US Immunology, Inflammation, and Early Clinical Translation at Innovent Biologics from August 2021 to March 2024. Prior experience also includes a role as Scientist II at MedImmune from May 2006 to December 2011. Yue Wang earned a Ph.D. in Microbiology/Immunology from the University of Alabama at Birmingham between 1996 and 2002.
Links